Aizaz Ali , Umar T. Ayub , Omar Obaid , Khaled Gharaibeh , Sadik A. Khuder , Naveed Akhtar , Adnan Qureshi , Mouhammad Jumaa , Ashfaq Shuaib
{"title":"The accuracy of ICH-FOS for spontaneous intracerebral hemorrhage: An analysis of ATACH-2 and the Qatar stroke database","authors":"Aizaz Ali , Umar T. Ayub , Omar Obaid , Khaled Gharaibeh , Sadik A. Khuder , Naveed Akhtar , Adnan Qureshi , Mouhammad Jumaa , Ashfaq Shuaib","doi":"10.1016/j.jocn.2025.111214","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Spontaneous intracranial hemorrhage(sICH) comprise between 15–20% of stroke with high rates of mortality and disability. Multiple scoring systems have been developed for sICH prognostication.</div></div><div><h3>Aims</h3><div>We explored the Qatar stroke database and the ATACH-2 database to study the independent predictors of 90-day mortality and poor functional outcomes[modified rankin score(mRS) 4–6] in patients with sICH. We compared admission national institute of health stroke scale (NIHSS) and Glasgow coma scale (GCS) with original intracerebral hemorrage(o-ICH), modified(m)ICH, ICH-GS(grading scale), Lanseed(LS)-ICH, Max-ICH, and ICH-FOS(functional outcome score) scores to evaluate 90-day mortality and functional outcomes.</div></div><div><h3>Methods</h3><div>Data on baseline characteristics, premorbid condition, laboratory tests, imaging findings, and surgical treatment were included. Outcomes were mortality and poor functional outcome(mRS 4–6) at 90-day follow-up. Prognostic accuracy of each score was assessed using Receiver Operating Characteristic(ROC) curve analysis. ICH-FOS risk categories were created for mortality and poor functional outcomes.</div></div><div><h3>Results</h3><div>There were 1660 patients with sICH admitted to Hamad General Hospital available for analysis. Mean age 49(SD 12) years, median GCS 15(IQR 11–15), median NIHSS 12(IQR 5–19). At 90-day follow-up, 124(11.3 %) died and 396(36 %) had poor functional outcome. ATACH included 1000 non-anti-coagulant related sICH patients with supratentorial bleeds without intra-ventricular extension(IVH). Mean age 62(SD 12) years, median GCS 15(IQR 13–15), median NIHSS 11(IQR 6–16). At 90-day follow-up, 54(5.9 %) patients died and 342(37.3 %) had poor functional outcomes. Patients in ATACH-2 were older, had 4-fold increased odds of having a prior stroke, and were 4-times more likely to be smokers. There were more lobar bleeds in Qatar and a higher proportion of patients in Qatar died at 90-days(11.3 v 5.9, p < 0.001). No difference in the rate of poor functional outcomes was noted. ICH-FOS had the largest AUC in ATACH(0.83, 95 % CI 0.77–0.89) and Qatar(0.81, 95 % CI 0.77–0.84) databases for predicting 3-month mortality, and similarly for unfavourable functional outcomes(mRS 4–6), with AUC’s in ATACH(0.83, 95 % CI 0.79–0.85) and Qatar(0.85, 95 % CI 0.82–0.87), respectively.</div></div><div><h3>Conclusion</h3><div>ICH-FOS was the most accurate predictor of 90-day mortality and poor functional outcome in both Qatari and ATACH-2 patients with non-anticoagulant related supratentorial sICH without IVH. Our study extends the utility of the ICH-FOS from a Chinese population to both Middle-Eastern and Western populations.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"136 ","pages":"Article 111214"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0967586825001869","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Spontaneous intracranial hemorrhage(sICH) comprise between 15–20% of stroke with high rates of mortality and disability. Multiple scoring systems have been developed for sICH prognostication.
Aims
We explored the Qatar stroke database and the ATACH-2 database to study the independent predictors of 90-day mortality and poor functional outcomes[modified rankin score(mRS) 4–6] in patients with sICH. We compared admission national institute of health stroke scale (NIHSS) and Glasgow coma scale (GCS) with original intracerebral hemorrage(o-ICH), modified(m)ICH, ICH-GS(grading scale), Lanseed(LS)-ICH, Max-ICH, and ICH-FOS(functional outcome score) scores to evaluate 90-day mortality and functional outcomes.
Methods
Data on baseline characteristics, premorbid condition, laboratory tests, imaging findings, and surgical treatment were included. Outcomes were mortality and poor functional outcome(mRS 4–6) at 90-day follow-up. Prognostic accuracy of each score was assessed using Receiver Operating Characteristic(ROC) curve analysis. ICH-FOS risk categories were created for mortality and poor functional outcomes.
Results
There were 1660 patients with sICH admitted to Hamad General Hospital available for analysis. Mean age 49(SD 12) years, median GCS 15(IQR 11–15), median NIHSS 12(IQR 5–19). At 90-day follow-up, 124(11.3 %) died and 396(36 %) had poor functional outcome. ATACH included 1000 non-anti-coagulant related sICH patients with supratentorial bleeds without intra-ventricular extension(IVH). Mean age 62(SD 12) years, median GCS 15(IQR 13–15), median NIHSS 11(IQR 6–16). At 90-day follow-up, 54(5.9 %) patients died and 342(37.3 %) had poor functional outcomes. Patients in ATACH-2 were older, had 4-fold increased odds of having a prior stroke, and were 4-times more likely to be smokers. There were more lobar bleeds in Qatar and a higher proportion of patients in Qatar died at 90-days(11.3 v 5.9, p < 0.001). No difference in the rate of poor functional outcomes was noted. ICH-FOS had the largest AUC in ATACH(0.83, 95 % CI 0.77–0.89) and Qatar(0.81, 95 % CI 0.77–0.84) databases for predicting 3-month mortality, and similarly for unfavourable functional outcomes(mRS 4–6), with AUC’s in ATACH(0.83, 95 % CI 0.79–0.85) and Qatar(0.85, 95 % CI 0.82–0.87), respectively.
Conclusion
ICH-FOS was the most accurate predictor of 90-day mortality and poor functional outcome in both Qatari and ATACH-2 patients with non-anticoagulant related supratentorial sICH without IVH. Our study extends the utility of the ICH-FOS from a Chinese population to both Middle-Eastern and Western populations.
自发性颅内出血(siich)占中风的15-20%,死亡率和致残率很高。多个评分系统已经开发用于脑出血的预测。目的:我们利用卡塔尔卒中数据库和ATACH-2数据库,研究siich患者90天死亡率和功能不良预后的独立预测因子[改良rank评分(mRS) 4-6]。我们比较了入院时国家健康研究所卒中量表(NIHSS)和格拉斯哥昏迷量表(GCS)与原始脑出血(o-ICH)、改良(m)ICH、ICH- gs(分级量表)、Lanseed(LS)-ICH、Max-ICH和ICH- fos(功能结局评分)评分,以评估90天死亡率和功能结局。方法纳入基线特征、病前状况、实验室检查、影像学表现和手术治疗等资料。90天随访结果为死亡率和功能不良(mRS 4-6)。采用受试者工作特征(ROC)曲线分析评估各评分的预后准确性。ICH-FOS风险分类是根据死亡率和不良功能结果创建的。结果哈马德总医院共收治sICH患者1660例。平均年龄49岁(SD 12),中位GCS 15(IQR 11-15),中位NIHSS 12(IQR 5-19)。在90天的随访中,124例(11.3%)死亡,396例(36%)功能预后不良。ATACH纳入了1000例伴有幕上出血且无室内扩张(IVH)的非抗凝相关siich患者。平均年龄62岁(SD 12),中位GCS 15(IQR 13-15),中位NIHSS 11(IQR 6-16)。在90天的随访中,54例(5.9%)患者死亡,342例(37.3%)患者功能预后不良。ATACH-2的患者年龄较大,先前中风的几率增加了4倍,吸烟的可能性增加了4倍。卡塔尔的大叶出血较多,90天内死亡比例较高(11.3 vs 5.9, p <;0.001)。功能不良结局发生率无差异。ICH-FOS在预测3个月死亡率的ATACH数据库中(0.83,95% CI 0.77-0.89)和Qatar数据库中(0.81,95% CI 0.77-0.84)的AUC最大,在预测不良功能结局(mRS 4-6)方面也是如此,ATACH数据库中的AUC分别为(0.83,95% CI 0.79-0.85)和Qatar数据库中的AUC分别为(0.85,95% CI 0.82-0.87)。结论ich - fos是卡塔尔和ATACH-2无IVH的非抗凝相关幕上sICH患者90天死亡率和功能不良预后的最准确预测因子。我们的研究将ICH-FOS的效用从中国人群扩展到中东和西方人群。
期刊介绍:
This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology.
The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.